10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2019 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2019 10-K (Filed: Feb 12, 2020) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
| Revenues: | |||
| Product sales | $ 23,362 | 23,747 | 22,849 |
| Total revenues | 23,362 | 23,747 | 22,849 |
| Operating expenses: | |||
| Cost of sales | 4,356 | 4,101 | 4,069 |
| Research and development | 4,116 | 3,737 | 3,562 |
| Selling, general and administrative | 5,150 | 5,332 | 4,870 |
| Other | 66 | 314 | 375 |
| Total operating expenses | 13,688 | 13,484 | 12,876 |
| Operating income | 9,674 | 10,263 | 9,973 |
| Interest expense, net | 1,289 | 1,392 | 1,304 |
| Interest and other income, net | 753 | 674 | 928 |
| Income before income taxes | 9,138 | 9,545 | 9,597 |
| Provision for income taxes | 1,296 | 1,151 | 7,618 |
| Net income | 7,842 | 8,394 | 1,979 |
| Earnings per share: | |||
| Basic (in usd per share) | 12.96 | 12.70 | 2.71 |
| Diluted (in usd per share) | 12.88 | 12.62 | 2.69 |
| Shares used in the calculation of earnings per share: | |||
| Basic (in shares) | 605 | 661 | 731 |
| Diluted (in shares) | 609 | 665 | 735 |
| Product and Service | |||
| Product sales | |||
| Product sales | 22,204 | 22,533 | 21,795 |
| Other | |||
| Product sales | 1,158 | 1,214 | 1,054 |
| Total revenues | 1,158 | 1,214 | 1,054 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2019 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2019 10-K (Filed: Feb 12, 2020) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
| Net income | $ 7,842 | 8,394 | 1,979 |
| Other comprehensive income (loss), net of reclassification adjustments and taxes: | |||
| (Losses) gains on foreign currency translation | (48) | (141) | 81 |
| (Losses) gains on cash flow hedges | (66) | 247 | (288) |
| Gains (losses) on available-for-sale securities | 360 | (185) | (6) |
| Other (losses) gains | (5) | (2) | 5 |
| Other comprehensive income (loss), net of taxes | 241 | (81) | (208) |
| Comprehensive income | 8,083 | 8,313 | 1,771 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2019 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2019 10-K (Filed: Feb 12, 2020) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
| Cash flows from operating activities: | |||
| Net income | $ 7,842 | 8,394 | 1,979 |
| Depreciation, amortization and other | 2,206 | 1,946 | 1,955 |
| Stock-based compensation expense | 308 | 311 | 329 |
| Deferred income taxes | (289) | (363) | (1,330) |
| Other items, net | 186 | (386) | (334) |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (504) | (378) | (58) |
| Inventories | (66) | (3) | 133 |
| Other assets | 10 | 35 | (24) |
| Accounts payable | 164 | (143) | 424 |
| Accrued income taxes, net | (585) | (361) | 523 |
| Long-term tax liabilities | (146) | 258 | 6,681 |
| Other liabilities | 396 | 1,214 | 231 |
| Net cash provided by operating activities | 9,150 | 11,296 | 11,177 |
| Cash flows from investing activities: | |||
| Purchases of marketable securities | (9,394) | (18,741) | (33,607) |
| Proceeds from sales of marketable securities | 8,842 | 28,356 | 24,240 |
| Proceeds from maturities of marketable securities | 20,548 | 5,412 | 6,174 |
| Purchases of property, plant and equipment | (618) | (738) | (664) |
| Cash paid for acquisitions, net of cash acquired | (13,617) | 195 | (19) |
| Other | (52) | (145) | (148) |
| Net cash provided by (used in) investing activities | 5,709 | 14,339 | (4,024) |
| Cash flows from financing activities: | |||
| Net proceeds from issuance of debt | 0 | 0 | 4,476 |
| Repayment of debt | (4,514) | (1,121) | (4,405) |
| Repurchases of common stock | (7,702) | (17,794) | (3,160) |
| Dividends paid | (3,509) | (3,507) | (3,365) |
| Withholding taxes arising from shares withheld for share-based payments | (137) | (126) | (191) |
| Other | 95 | 58 | 51 |
| Net cash used in financing activities | (15,767) | (22,490) | (6,594) |
| (Decrease) increase in cash and cash equivalents | (908) | 3,145 | 559 |
| Cash and cash equivalents at beginning of year | 6,945 | 3,800 | |
| Cash and cash equivalents at end of year | 6,037 | 6,945 | 3,800 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
AMGEN INC | ||
Ticker: AMGN Fiscal Year: 2019 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2019 10-K (Filed: Feb 12, 2020) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2019 | Dec 31, 2018 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $ 6,037 | 6,945 |
| Marketable securities | 2,874 | 22,359 |
| Trade receivables, net | 4,057 | 3,580 |
| Inventories | 3,584 | 2,940 |
| Other current assets | 1,888 | 1,794 |
| Total current assets | 18,440 | 37,618 |
| Property, plant and equipment, net | 4,928 | 4,958 |
| Intangible assets, net | 19,413 | 7,443 |
| Goodwill | 14,703 | 14,699 |
| Other assets | 2,223 | 1,698 |
| Total assets | 59,707 | 66,416 |
| LIABILITIES AND STOCKHOLDERS EQUITY | ||
| Current liabilities: | ||
| Accounts payable | 1,371 | 1,207 |
| Accrued liabilities | 8,511 | 7,862 |
| Current portion of long-term debt | 2,953 | 4,419 |
| Total current liabilities | 12,835 | 13,488 |
| Long-term debt | 26,950 | 29,510 |
| Long-term deferred tax liabilities | 606 | 864 |
| Long-term tax liabilities | 8,037 | 8,770 |
| Other noncurrent liabilities | 1,606 | 1,284 |
| Contingencies and commitments | ||
| Stockholders equity: | ||
| Common stock and additional paid-in capital; $0.0001 par value per share; 2,750.0 shares authorized; outstanding591.4 shares in 2019 and 629.6 shares in 2018 | 31,531 | 31,246 |
| Accumulated deficit | (21,330) | (17,977) |
| Accumulated other comprehensive loss | (528) | (769) |
| Total stockholders equity | 9,673 | 12,500 |
| Total liabilities and stockholders equity | 59,707 | 66,416 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2019 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |